对T细胞淋巴瘤患者的长期结果的现实数据:韩国全国性研究
Dong Won Baek1, Jung Min Lee1, Youngeun Jang1
1Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.
Blood research
|August 21, 2025
概括
含有埃托波的化疗和自身干细胞移植改善了外围T细胞淋巴瘤 (PTCL) 的结果. 在接受这些治疗的PTCL患者中,该研究突显了无进展生存率 (PFS) 和整体生存率 (OS) 的改善.
科学领域:
- 血液学
- 癌症学
- 临床研究
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 是一种罕见,侵袭性和异质的癌症.
- 了解PTCL的治疗模式和结果对于改善患者护理至关重要.
研究的目的:
- 对韩国PTCL患者进行全面分析.
- 评估治疗结果,包括移植和长期存活.
主要方法:
- 对国家医疗保险服务数据的回顾性分析.
- 包括诊断为成熟的T细胞和NK/T细胞淋巴瘤的患者 (2005-2022年).
- 对发病率,生存结果和治疗效果的分析.
主要成果:
- 最常见的是PTCL- Not Else Specified (NOS) 和外节NK/ T细胞淋巴瘤.
- 添加埃托的CHOP化疗改善了无进展生存 (PFS) 和整体生存 (OS).
- 自体干细胞移植 (ASCT) 显著增强了PFS和OS,特别是在PTCL- NOS和血管免疫性T细胞淋巴瘤 (AITL) 中.
结论:
- 含有乙氧化物的CHOP疗法可以改善PTCL的治疗结果.
- 巩固性自身干细胞移植 (ASCT) 对PTCL-NOS和AITL亚型提供了生存益处.
更多相关视频
12:16A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
14.9K
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
193
相关概念视频
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
